Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr 22;3(7):855-866.
doi: 10.1002/hep4.1358. eCollection 2019 Jul.

Platelets and Platelet-Derived Extracellular Vesicles in Liver Physiology and Disease

Alexandre Balaphas  1   2   3 , Jeremy Meyer  1   2   3 , Karin Sadoul  4 , Pierre Fontana  5   6 , Philippe Morel  1   2   3 , Carmen Gonelle-Gispert  2   3 , Leo H Bühler  1   2   3
Affiliations
Review

Platelets and Platelet-Derived Extracellular Vesicles in Liver Physiology and Disease

Alexandre Balaphas et al. Hepatol Commun. .

Abstract

Beyond their role in hemostasis, platelets are proposed as key mediators of several physiological and pathophysiological processes of the liver, such as liver regeneration, toxic or viral acute liver injury, liver fibrosis, and carcinogenesis. The effects of platelets on the liver involve interactions with sinusoidal endothelial cells and the release of platelet-contained molecules following platelet activation. Platelets are the major source of circulating extracellular vesicles, which are suggested to play key roles in platelet interactions with endothelial cells in several clinical disorders. In the present review, we discuss the implications of platelet-derived extracellular vesicles in physiological and pathophysiological processes of the liver.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Roles of platelets and PEVs in ischemia‐reperfusion injury and acute liver injury. (A) After liver ischemia‐reperfusion injury and acute liver injury, such as hepatectomy, activated platelets in the sinusoid release several growth factors that can directly stimulate hepatocytes to proliferate or activate LSECs to further produce growth factors or factors, such as IL‐6, that regulate liver regeneration. (B) PEVs have opposite effects on the liver after injury. (B1) In ischemia/reperfusion, PEVs activate c‐jun N‐terminal kinase and nuclear factor‐kappa B in hepatocytes and contribute to cell injury. (B2) After acute liver injury and ischemia/reperfusion, PEVs can induce endothelium activation, which further promotes the recruitment, adhesion, and migration of monocytes and neutrophils and the secretion of cytokines, such as IL‐6. (B3) We propose that growth factor production by LSECs could modulate liver regeneration. Moreover, PEVs might have a direct effect on hepatocytes.
See this image and copyright information in PMC

References

    1. Pietrzak WS, Eppley BL. Platelet rich plasma: biology and new technology. J Craniofac Surg 2005;16:1043‐1054. - PubMed
    1. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105(Suppl 1):S13‐S33. - PubMed
    1. Xu X, Zhu F, Zhang M, Zeng D, Luo D, Liu G, et al. Stromal cell‐derived factor‐1 enhances wound healing through recruiting bone marrow‐derived mesenchymal stem cells to the wound area and promoting neovascularization. Cells Tissues Organs 2013;197:103‐113. - PubMed
    1. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004;91:4‐15. - PubMed
    1. Mazzucco L, Borzini P, Gope R. Platelet‐derived factors involved in tissue repair‐from signal to function. Transfus Med Rev 2010;24:218‐234. - PubMed